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Background: To examine the utility of DNA microarray analysis for identifying causative 
microorganisms in endophthalmitis.
Methods: Thirteen samples of vitreous fluid (VF) were obtained from 13 patients during 
  vitrectomy. Vitreous fluids from three patients with suspected endophthalmitis and ten controls 
without infection were subjected to testing for the presence of bacteria and fungi in culture tests, 
polymerase chain reaction (PCR) analysis, and DNA microarray analysis.
Results: No control sample was positive for bacteria or fungi in the culture test, PCR, or 
microarray analysis. Specimens from two patients (Cases 1 and 2) with suspected endophthalmitis 
were positive for bacteria in PCR, and a specimen from one patient (Case 3) was positive for 
fungi in PCR. Klebsiella pneumonia (Case 1), Streptococcus agalactiae (Case 2), and Candida 
parapsilosis (Case 3) in the PCR-positive specimens were identified by DNA microarray analysis 
within 24 hours. Culture results were also positive for K. pneumonia in Case 1, S. agalactiae 
in Case 2, and C. parapsilosis in Case 3, but required 3 to 4 days to obtain.
Conclusions: Microarray analysis is complementary to routine cultures for identifying causative 
microorganisms and is likely to be a useful tool in patients with suspected endophthalmitis who 
require rapid diagnosis and early antibiotic treatment.
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Introduction
Endophthalmitis is a devastating ocular disorder that leads to visual blindness. Rapid 
detection and identification of the causative pathogens is crucial for vision-saving 
diagnosis and treatment. Molecular techniques using multiplex or broad-range PCR 
enable rapid detection and identification of causative pathogens in ocular infectious 
diseases.1–3 Several problems remain to be solved, however. Multiplex PCR has the 
drawback of allowing only a limited number of genes to be analyzed in one reaction, 
and pre-identification of the species level is required. Analysis of amplicons by DNA 
sequencing, after broad-range PCR, are the most used techniques for identifying 
DNA, but the time and effort associated with data analysis lead to some limitations. 
Therefore, improved high-throughput genotyping methods that are sensitive and 
discriminative are needed.
DNA microarray technology is a promising genotyping method that allows simul-
taneous identification of a wide variety of genes4–8 and rapid determination of the 
genetic profile of a microorganism in a single experiment.6–8 Thus, this method may 
be useful for genetic screening and identification of microorganisms. The aim of this 
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study was to examine the utility of DNA microarray 
analysis for identifying causative microorganisms in 
endophthalmitis.
Materials and Methods
Clinical sample collection
Thirteen samples of vitreous fluid (VF) obtained from 
13 patients during vitrectomy were prospectively analyzed 
at our university hospital. Informed consent was obtained 
from each patient after an explanation of the purpose and 
potential adverse effects of the procedure. This study was per-
formed in accordance with the Helsinki Declaration of 1975 
(1983 revision) and the institutional review boards of Jikei 
University. VF samples were collected from three subjects 
with clinically diagnosed endophthalmitis, and control VF 
samples were obtained from ten subjects undergoing vitrec-
tomy for macular hole, epiretinal membrane, retinal detach-
ment, and proliferative vitreoretinopathy. VF samples were 
obtained under sterile operating conditions by aspiration with 
a syringe connected to the suction port of the vitreous cutter 
at the beginning of the vitrectomy procedure. The samples 
were divided in half, with one portion used for conventional 
microbiological tests in the bacteriology laboratory of our 
university hospital and the other for PCR and microarray 
analysis in the Institute of Medical Technology.
Bacterial isolation and conventional 
identification methods
VF was stained using the Gram method for detection of bacte-
ria and a 10% potassium hydroxide calcofluor white prepara-
tion for detection of fungi. Standard methods were followed 
for isolation and identification of bacteria and fungi.
DNA purification and PCR amplification
Genomic DNA was extracted from 50 µL of VF accord-
ing to the protocol of the QIAamp kit (Qiagen, Valencia, 
CA) and DNA was eluted in 50 µL of QIAamp AE buffer. 
An aliquot of 2 µL of the DNA template was used in each 
amplification reaction. The 16S ribosomal ribonucleic acid 
gene (16S rDNA) was amplified from genomic DNA using a 
broad-spectrum PCR primer 5′-AGA GTT TGA TCC TGG 
CTC AG-3′ corresponding to Escherichia coli 16S rDNA 
positions 8–27, and 5′-GTA TTA CCG CGG CTG CTG 
G-3′, corresponding to E. coli 16S rRNA gene positions 
517–535. The PCR primer 5′-TCC GTA GGT GAA CCT 
GCG G-3′, 5′-GCT GCG TTC TTC ATC GAT GC-3′ was 
used to amplify the internal transcribed spacer (ITS) 1 region. 
The standard PCR mixture (25 µl) contained 0.75 U of Taq 
DNA polymerase (AmpliTaq DNA polymerase, LD; Applied 
Biosystems, Foster City, CA), 1 × reaction buffer, 2.5 mM 
MgCl2, 0.4 mM (each) dNTP mix, 250 nM (each) forward 
and reverse primers, and 2 µL of DNA template. PCR was 
performed with a Gene Amp PCR system 9600 thermocy-
cler (Applied Biosystems) under the following conditions: 
initial activation at 94°C for 3 minutes; 35 cycles at 94°C for 
30 seconds, 55°C for 60 seconds, and 72°C for 30 seconds; 
and final extension at 72°C for 3 minutes. The PCR prod-
ucts were separated by electrophoresis in 3% agarose gels 
containing 1 × Tris-acetate-EDTA buffer and visualized by 
staining with ethidium bromide.
Detection of bacterial and fungal DNA  
by DNA microarray
We have previously developed a microarray assay, for 
identification of 76 bloodstream infection-associated 
pathogens (bacteria and fungi) from whole blood samples.7,8 
This pathogen identification microarray is an assay for parallel 
identification of bacterial species and clinically relevant 
Candida species.8 Bacterial and fungal sequence data were 
obtained directly from the GenBank database. The 16S rDNA 
PCR products from clinical isolates were sequenced using 
an automated sequencer (Applied Biosystems) and variable 
regions were aligned using ClustalW (http://www.ebi.ac.uk/
Tools/clustalw2/index. html) to identify the 500-bp sequence 
of 16S rDNA at the 5′ end, including variable regions (V1, V2, 
V3). Fungus-specific primers were targeted to the conserved 
sequences of 5.8S and 18S, including the ITS1 region. The 
theoretical specificities of all designed primer and probe 
sequences were further analyzed using BLAST (NCBI). 
The oligonucleotide probes (50 bp), corresponding to the 
variable regions and PCR products that were amplified by 
the 27f primer and r1 L primer, were spotted onto plastic 
slides using a microarray-making instrument (SPBIO; 
Hitachi Soft Engineering, Yokohama, Japan). The sequences 
of the 76 microorganism probes have been described 
previously.8 Each probe identifies the sequence of each of the 
76 microorganisms, which include all causal clinical disease 
pathogens (patent no. WO2003/106676).
Labeling and DNA hybridization
The PCR products from samples were labeled with Cy5 
primers of sequences 5′-Cy5-CTC ACC CGT-3′ (Cy5 120R), 
5′-Cy5-TGC CTC CCG-3′ (Cy5 350R), and 5′-Cy5-TGC 
TGG CAC-3′ (Cy5 520R). For the ITS region, the primer 
sequence was 5′-Cy5-GCT GCG TTC TTC ATC GAT GC-3′ 
(Cy5 ITS2). The labeling reaction was performed in 20 cycles 
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(37°C for 5 seconds and 94°C for 5 seconds) using a thermal 
cycler. Hybridization of the labeled samples to the microar-
ray was carried out in 1 × hybridization buffer composed 
of 40% formamide, 5 × saline-sodium citrate (SSC) buffer, 
and 0.2% sodium dodecyl sulfate (SDS) at 55°C for 1 hour. 
Before hybridization, 50 µL of the Cy5-labeled sample was 
mixed with 150 µL of 1.5 × hybridization buffer, followed 
by denaturing at 96°C for 2 minutes and chilling on ice. 
Each sample was placed on the microchip and covered with 
a 40 × 22 × 0.25 mm plastic chamber (Invitrogen, Carlsbad, 
CA) to prevent evaporation of the probe during incubation. 
After hybridization, the slides were washed for 5 minutes 
with 2 × SSC exposed to 0.2% SDS at room temperature, and 
then rinsed for 5 minutes with 0.2 × SSC exposed to 0.2% 
SDS warmed to 50°C in a water bath. Finally, the slides were 
rinsed with 0.05 × SSC and dried in a stream of air.
Fluorescence scanning and automated 
data analysis
Fluorescent images of the microarrays were obtained by 
scanning the slides with ScanArray 5000 (Perkin-Elmer, 
Boston, MA). The fluorescent signals from each spot were 
measured and compared using DNASIS Array software 
(Hitachi Software Engineering, Yokahama, Japan). A scan 
image is shown in Figure 1. Identification of the microorgan-
ism was made by automatic statistical recognition of a certain 
pattern of positive spots, as described previously.7,8
Results
No control sample was positive for bacteria or fungi in 
microscopy, culture tests, PCR, or microarray analysis. The 
samples from Cases 1 and 2 were positive for bacteria in 
PCR analysis of VF specimens, and the sample from Case 3 
was positive for fungus in PCR analysis. The DNA microar-
ray was used to detect bacterial and fungal pathogens from 
positive PCR specimens. Data analysis revealed increased 
expression levels of genes from specific microorganisms 
in the VF samples. DNA microarray analysis identified 
Klebsiella pneumonia in Case 1 (Figure 2), Streptococcus 
agalactiae in Case 2 (Figure 3), and Candida parapsilosis in 
Case 3 (Figure 4) in the PCR-positive specimens. The results 
of the culture tests required 3 to 4 days to obtain, and were 
similarly positive for K. pneumonia in Case 1, S. agalactiae 
in Case 2, and C. parapsilosis in Case 3. The following 
paragraphs provide some background on each case.
Case reports
Case 1: A 56-year-old man with a history of diabetes mel-
litus for 10 years had a sudden onset of high fever. He was 
treated with systemic piperacillin sodium (PIPC) (IV) for 
V3 V2 V1 Top 500
Figure 1 Scheme of DNA microarray. Probes of polymerase chain reaction products 
and each of the variable regions (V1, V2, V3) are arrayed on the plastic slide.
V3 V2 V1 PCR
Figure 2 results of the hybridization assay for polymerase chain reaction (PCr) 
amplifications  from  vitreous  sample  of  case  1.  PCR  products  are  spotted  as 
a reference on the right side. green or blue (arrow) circles in V1, V2, and V3 
represent  strong  hybridization.  Bacterial  identification  is  determined  by  the 
combination of strong hybridization in V1, V2, and V3. This case shows a pattern of 
Klebsiella pneumonia.
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K. pneumoniae by DNA microarray analysis (Figure 2). 
Ten days after his initial visit, a vitreous culture revealed 
K. pneumonia. His final vision was hand motion.
Case 2: A 74-year-old man with periodontitis visited our 
department complaining of severe visual loss in his left eye, 
and was diagnosed with endophthalmitis. His vision was 
20/20 OD and light perception was OS. The patient was 
treated with systemic PIPC (IV) and the infection focus 
was examined at the same time. An initial blood examination 
showed that he had severe diabetes. Two days after his initial 
visit, vitrectomy was performed and vitreous samples were 
collected for culture tests and PCR analysis. Immediate PCR 
V3 V2 V1 PCR
Figure 3 results of the hybridization assay for polymerase chain reaction (PCr) 
amplifications  from  vitreous  sample  of  case  2.  PCR  products  are  spotted  as  a 
reference in the right side. green or blue (arrow) circles in V1, V2, and V3 represent 
strong hybridization. Bacterial identification is determined by the combination of 
strong hybridization in V1, V2, and V3. This case shows a pattern of Streptococcus 
agaractiae.
V3 V2 V1 PCR
Figure 4 results of the hybridization assay for polymerase chain reaction (PCr) 
amplifications  from  vitreous  sample  of  case  2.  PCR  products  are  spotted  as  a 
reference in the right side. green or blue (arrow) circles in V1, V2, and V3 represent 
strong hybridization. Fungal identification is determined by the combination of strong 
hybridization in V1, V2, and V3. This case shows a pattern of Candida parapsilosis.
7 days. On day 7 he complained of abdominal pain and loss 
of vision OD, and was referred to our hospital. On exami-
nation, his vision was hand motion OD and 20/20 OS. An 
anterior and posterior segment examination revealed severe 
inflammation with hypopyon and vitreous haze, respectively. 
An abdominal CT scan showed a low-density mass in the 
liver consistent with a liver abscess. Septic and metastatic 
endophthalmitis were diagnosed and the patient was treated 
with meropenem + gentamicin. Seven days after his initial 
visit, vitrectomy was performed and vitreous samples were 
collected for culture tests and PCR analysis. Immediate PCR 
was positive for bacteria, with subsequent identification of 
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was positive for bacteria, with subsequent identification of 
S. agalactiae (Figure 3) by DNA microarray analysis. Five 
days after his initial visit, vitreous and oral adherent smear 
cultures revealed the presence of S. agalactiae. His vision 
subsequently improved to 20/200.
Case 3: The patient was a 72-year old female who visited 
our hospital with a complaint of dull pain and photophobia 
in the left eye. She had undergone cataract surgery in the 
left eye 3 months earlier, with no complications during the 
surgery. Her medical history included diabetes mellitus 
for 20 years. On examination, corrected visual acuity was 
20/20 OD and 20/200 OS. An anterior segment examina-
tion was significant for keratic precipitates and hypopyon 
in the left eye. Ophthalmoscopy was normal in the right eye 
but showed vitreous extension of chorioretinal infiltrates, 
associated with vitreous cells and fluff balls in the left eye. 
Endophthalmitis was diagnosed and systemic PIPC (IV) 
were initiated, although culture of aqueous humor and blood 
were investigated before systemic treatment. After 2 days, 
her vision had worsened to hand motion and a vitrectomy 
with biopsy was performed. Immediate PCR was positive 
for fungus, with subsequent identification of C. parapsilosis 
(Figure 4) by DNA microarray analysis. Seven days after her 
initial visit, a vitreous culture similarly revealed the presence 
of C. parapsilosis, although culture results of aqueous humor 
and blood were negative. Systemic antibiotics were stopped 
and antifungal therapy was initiated after confirmation by 
culture. Her final vision was hand motion.
Discussion
The DNA microarray that we developed for bacterial and 
fungal pathogens in blood samples permitted identification 
of these pathogens in VF samples from patients with 
endophthalmitis. Our prototype microarray analysis 
demonstrates the feasibility of identifying pathogens in 
0.2 mL of VF without prior amplification of the target DNA. 
Furthermore, the results suggest that DNA microarray analysis 
is more rapid than conventional bacteriological methods for 
identifying causative pathogens in endophthalmitis. The 
PCR analysis in our laboratory takes approximately 48 hours 
to detect microorganisms. Standard clinical identification 
procedures require at least 3 days and can take up to 3 weeks 
for microorganisms that are difficult to cultivate. In contrast, 
the microarray protocol can be carried out within 24 hours 
from drawing of VF to software presentation of the results, 
and gel electrophoresis for PCR product confirmation and 
prehybridization can be carried out in parallel with the 
labeling reaction. Consequently, the microarray is likely to 
be useful in patients who require prompt diagnosis and early 
initiation of antibiotic therapy.
In the present study, the sensitivity and the specificity 
of the microarray analysis were both 100.0% in comparison 
with the culture results. This suggests that the microarray 
data are reliable for identification of microorganisms from 
VF in endophthalmitis. A previous study of detection of 
pathogens in osteoarticular infections using our microar-
ray showed discrepancies for some samples. Although the 
current study did not have this problem, false positives and 
negatives in the microarray analysis should be considered 
carefully in endophthalmitis. Taq DNA polymerase in PCR 
is produced and purified by E. coli and genomic DNA from 
the sample may contaminate the target gene; however, we 
have shown the lack of such contamination. Sampling should 
also be performed carefully to obtain correct bacterial and 
fungal identification.
Bacterial and fungal endophthalmitis can occur in surgery 
(postoperative), after trauma caused by a penetrating foreign 
body (posttraumatic), or during metastasis from a distant 
infection site (endogenous).9 In postoperative cases, coagu-
lase-negative staphylococcal isolates are the most common 
pathogens. Other species include Staphylococcus aureus, 
streptococci, and enterococci, and Gram-positive rods such 
as Bacillus. In post-traumatic cases, staphylococci are the 
most common isolates, with B. cereus ranked as the second 
most common cause. In endogenous cases, Klebsiella spp. is 
the most common cause of Gram-negative bacteria. Among 
Gram-positive endogenous endophthalmitis,   Bacillus spp. 
and coagulase-negative staphylococci are the most common 
causes. Our microarray covers the clinically common micro-
organisms in endophthalmitis, and the results of this study 
suggest that the microarray analysis is a valuable molecu-
lar tool for identifying causal agents in   endophthalmitis. 
Although three endophthalmitis cases we presented are 
not the usual acute postoperative endophthalmitis cases in 
the present study, we believe that our microarray would be 
useful for detecting intraocular pathogens in the usual acute 
postoperative endophthalmitis cases, since this pathogen 
identification microarray has also allowed identification of 
infection-associated pathogens (bacteria and fungi) from 
various samples.7,8
The advantages of microarray analysis include parallel 
identification of different microorganisms in one assay, 
in contrast to multiplex or broad-range PCR methods. In 
a previous study, Kunimoto et al10 reported that 12.5% of 
culture-positive cases in postoperative endophthalmitis had 
polymicrobial infection. The high rate reflected the   inclusion 
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of fungal isolates in this series. Furthermore, Anand et al11 
have shown that conventional methods of microscopy and 
cultures are less sensitive and time consuming diagnos-
tic tools compared with PCR in the diagnosis of fungal 
endophthalmitis, because of the small number of organisms in 
the eye and the small sample size of the intraocular specimen 
collected. Thus, rapid detection capability of polymicrobial 
infection and identification of microorganisms using the 
microarray is valuable in the diagnosis of endophthalmitis.
The main limitation of the study is sample size. The 
number of ocular specimens is too low to fully evaluate the 
microarray analysis. However, although the results may be 
preliminary, this is the first report of use of this technology in 
endophthalmitis. We believe that a future, large scale, study 
may provide useful information for clinical care. The DNA 
microarray has potential as a clinical tool for microbiological 
diagnosis in endophthalmitis, and this will allow ophthal-
mologists to administer appropriate antibiotic therapy in a 
timely fashion and to improve the outcome for vision.
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